These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37127633)

  • 1. Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone.
    Fombah AE; Chen H; Owusu-Kyei K; Quinto L; Gonzalez R; Williams J; Berne ML; Wassenaar M; Jalloh A; Sunders JC; Ramirez M; Bertran-Cobo C; Saute F; Ekouevi DK; Briand V; Kamara ARY; Sesay T; Samai M; Menendez C
    Malar J; 2023 May; 22(1):145. PubMed ID: 37127633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of health system readiness and coverage of intermittent preventive treatment of malaria in infants (IPTi) in Kambia district to inform national scale-up in Sierra Leone.
    Lahuerta M; Sutton R; Mansaray A; Eleeza O; Gleason B; Akinjeji A; Jalloh MF; Toure M; Kassa G; Meshnick SR; Deutsch-Feldman M; Parmley L; Friedman M; Smith SJ; Rabkin M; Steinhardt L
    Malar J; 2021 Feb; 20(1):74. PubMed ID: 33549098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.
    Dicko A; Toure SO; Traore M; Sagara I; Toure OB; Sissoko MS; Diallo AT; Rogier C; Salomon R; de Sousa A; Doumbo OK
    BMC Public Health; 2011 Jul; 11():573. PubMed ID: 21767403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J; Sismanidis C; Goodman T; Milligan P;
    Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.
    Dicko A; Sagara I; Djimdé AA; Touré SO; Traore M; Dama S; Diallo AI; Barry A; Dicko M; Coulibaly OM; Rogier C; de Sousa A; Doumbo OK
    Malar J; 2010 Jan; 9():9. PubMed ID: 20064223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.
    Mockenhaupt FP; Reither K; Zanger P; Roepcke F; Danquah I; Saad E; Ziniel P; Dzisi SY; Frempong M; Agana-Nsiire P; Amoo-Sakyi F; Otchwemah R; Cramer JP; Anemana SD; Dietz E; Bienzle U
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3273-81. PubMed ID: 17638703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent preventive treatment for malaria in infants.
    Esu EB; Oringanje C; Meremikwu MM
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011525. PubMed ID: 34273901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster-randomized controlled trial of intermittent preventive treatment in infancy using sulfadoxine-pyrimethamine (SP-IPTi): a pilot study in Nigeria.
    Adeleke OT; Oyenuga A; Slusher TM; Gbadero DA
    J Trop Pediatr; 2022 Dec; 69(1):. PubMed ID: 36633492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Aponte JJ; Schellenberg D; Egan A; Breckenridge A; Carneiro I; Critchley J; Danquah I; Dodoo A; Kobbe R; Lell B; May J; Premji Z; Sanz S; Sevene E; Soulaymani-Becheikh R; Winstanley P; Adjei S; Anemana S; Chandramohan D; Issifou S; Mockenhaupt F; Owusu-Agyei S; Greenwood B; Grobusch MP; Kremsner PG; Macete E; Mshinda H; Newman RD; Slutsker L; Tanner M; Alonso P; Menendez C
    Lancet; 2009 Oct; 374(9700):1533-42. PubMed ID: 19765816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
    Chandramohan D; Owusu-Agyei S; Carneiro I; Awine T; Amponsa-Achiano K; Mensah N; Jaffar S; Baiden R; Hodgson A; Binka F; Greenwood B
    BMJ; 2005 Oct; 331(7519):727-33. PubMed ID: 16195288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.
    de Sousa A; Rabarijaona LP; Ndiaye JL; Sow D; Ndyiae M; Hassan J; Lambo N; Adovohekpe P; Guidetti F; Recht J; Affo A
    Trop Med Int Health; 2012 Mar; 17(3):308-15. PubMed ID: 22128893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent preventive treatment for malaria in infants.
    Esu EB; Oringanje C; Meremikwu MM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011525. PubMed ID: 31792925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria Intermittent Preventive Treatment (IPTi) pharmacovigilance in Malawi: A case of Lilongwe district.
    Kubalalika PJ
    Online J Public Health Inform; 2019; 11(2):e9. PubMed ID: 31632603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival.
    Schellenberg JR; Maokola W; Shirima K; Manzi F; Mrisho M; Mushi A; Alonso P; Mshinda H; Tanner M; Schellenberg DM
    Malar J; 2011 Dec; 10():387. PubMed ID: 22208409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced efficacy of intermittent preventive treatment of malaria in malnourished children.
    Danquah I; Dietz E; Zanger P; Reither K; Ziniel P; Bienzle U; Mockenhaupt FP
    Antimicrob Agents Chemother; 2009 May; 53(5):1753-9. PubMed ID: 19223620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control.
    Manzi F; Hutton G; Schellenberg J; Tanner M; Alonso P; Mshinda H; Schellenberg D
    BMC Health Serv Res; 2008 Jul; 8():165. PubMed ID: 18671874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control.
    Dicko A; Konare M; Traore D; Testa J; Salamon R; Doumbo O; Rogier C
    Malar J; 2012 Mar; 11():73. PubMed ID: 22423611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi).
    Kobbe R; Adjei S; Kreuzberg C; Kreuels B; Thompson B; Thompson PA; Marks F; Busch W; Tosun M; Schreiber N; Opoku E; Adjei O; Meyer CG; May J
    Malar J; 2007 Dec; 6():163. PubMed ID: 18067679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.